China Sky One Medical (中国天字一号医药公司) announced further additions to its ever-larger portfolio of pharmaceutical products. The company reported the SFDA approved production of two new drugs, bringing to 25 the total number of approvals for China Sky One Medical since January 2008. Another 20 products are in the application process. More details...
Stock Symbol: (NSDQ: CSKI)
Sorry... this feature or article is only available to subscribers.